GlassScriptPhysician profile
Kelli Miller
NPI 1245327097
$5,417.31
in general payments reported to CMS, 2019-2025
23 companies · $2,886 in 2025
The $2,886 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.62 · 2020: $12.38 · 2021: $1,539 · 2022: $192 · 2023: $347 · 2024: $407 · 2025: $2,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,450 · Food and Beverage: $1,090 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,450.00 |
| Food and Beverage | $1,089.73 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $3,785.72 | 2021-2025 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Acessa Health INC. | $350.00 | 2025 | Acessa Provu System |
| Aspira Women'S Health INC | $246.66 | 2022-2023 | Ova1 |
| Boston Scientific Corporation | $193.85 | 2025 | Solyx Sis System |
| Gynesonics, INC. | $143.11 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $129.94 | 2021-2024 | Veozah |
| Abbvie INC. | $117.46 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $73.05 | 2023-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $51.50 | 2023-2025 | Gardasil 9, Gardasil |
| Channel Medsystems, INC. | $36.34 | 2024 | |
| Coopersurgical, INC. | $33.82 | 2022-2024 | Paragard T 380a |
| Coloplast Corp | $32.07 | 2025 | |
| Ethicon US, LLC | $30.75 | 2019-2020 | |
| Amgen INC. | $28.59 | 2021-2024 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $27.64 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $21.67 | 2024 | Tisseel |
| Novo Nordisk INC | $21.10 | 2024 | Wegovy |
| Pacira Pharmaceuticals Incorporated | $18.17 | 2024 | Exparel |
| Therapeuticsmd, INC. | $16.25 | 2019 | |
| Millicent US INC | $15.53 | 2025 | Femlyv |
| Pharmacosmos Therapeutics INC. | $15.28 | 2023 | Monoferric |
| Exact Sciences Corporation | $15.12 | 2025 | Cologuard Collection Kit |
| Exeltis, USA INC. | $13.69 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.